Digital Marketing Trends in Psoriasis
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
Digital Marketing Trends in Psoriasis Report Overview
AbbVie’s Skyrizi.com accounted for the highest traffic across branded psoriasis (PsO) patient sites in the US, with around three million visitors from January 2023 to December 2023. This was followed by Amgen’s Otezla.com (1.7 million visits). Overall, the highest proportion of traffic to top branded patient PsO websites originated from organic sources, followed by direct searches.
Buy the Full Report to get More Insights into the Digital Marketing Trends in Psoriasis
Download a Free Report Sample
The ‘Digital Marketing Trends in Psoriasis’ report provides an analysis of key digital marketing metrics of pharma assets in PsO, including branded websites for patients and HCPs, unbranded websites, and social media accounts. Furthermore, the report enlists metrics such as website traffic volume, engagement, source, DDA, paid SEO, and social media post interaction.
| Key US Branded Websites for Patients | · AbbVie’s Skyrizi.com
· Amgen’s Otezla.com · AbbVie’s Humira.com · Novartis’s Cosentyx.com · Janssen’s Tremfya.com |
| Key US Branded HCP Websites for Psoriasis | · Amgen’s Otezla.com
· AbbVie’s Skyrizihcp.com · Amgen’s Enbrelpro.com · Novartis’s Cosentyxhcp.com · AbbVie’s Humira.com |
| Key EUCAN Branded Websites for Psoriasis | · Abbvie-care.de
· Ucbcares.de · Abbviecare.fr |
| Key EUCAN Unbranded Websites for Psoriasis | · Novartis’s Psoriasis.info
· Jassen’s anssenwithme.de · Novartis’s Lapelleconta.it |
| Enquire & Decide |
Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Key US Branded Patient Websites for Psoriasis
The key US-branded patient websites for psoriasis are AbbVie’s Skyrizi.com, Amgen’s Otezla.com, AbbVie’s Humira.com, Novartis’s Cosentyx.com, and Janssen’s Tremfya.com, among others. AbbVie’s Skyrizi.com achieved the highest traffic from January 2023 to December 2023 across US psoriasis patient sites, followed by Amgen’s Otezla.com.
Digital Marketing Trends in Psoriasis Analysis by US Branded Patient Websites, January 2023-December 2023
Buy the Full Report to Get More Insights into the US Branded Patient Websites for Psoriasis
Download a Free Report Sample
Key US Branded HCP Websites for Psoriasis
The key US-branded HCP websites for psoriasis are Amgen’s Otezla.com, AbbVie’s Skyrizihcp.com, Amgen’s Enbrelpro.com, Novartis’s Cosentyxhcp.com, and AbbVie’s Humira.com, among others. Amgen’s Otezlapro.com achieved the highest traffic across Psoriasis HCP sites in the US from January 2023 to December 2023.
Digital Marketing Trends in Psoriasis Analysis by US Branded HCP Websites, January 2023-December 2023
Buy the Full Report to Get More Insights into the US Branded HCP Websites for Psoriasis
Download a Free Report Sample
Key EUCAN Branded Websites for Psoriasis
The key EUCAN-branded websites for psoriasis are Abbvie-care.de, Ucbcares.de, and Abbviecare.fr. Abbvie-care.de achieved the highest traffic across psoriasis-branded sites in EUCAN between January 2023 and December 2023.
Digital Marketing Trends in Psoriasis Analysis by EUCAN Branded Websites, January 2023-December 2023
Buy the Full Report to Get More Insights into the EUCAN Branded Websites for Psoriasis
Download a Free Report Sample
Key EUCAN Unbranded Websites for Psoriasis
The key EUCAN unbranded websites for psoriasis are Novartis’s Psoriasis.info, Jassen’s anssenwithme.de, and Novartis’s Lapelleconta.it. Novartis’s Psoriasis.info achieved the highest traffic across psoriasis unbranded sites in EUCAN between January 2023 and December 2023.
Digital Marketing Trends in Psoriasis Analysis by EUCAN Unbranded Websites, January 2023-December 2023
Buy the Full Report to Get More Insights into the EUCAN Unbranded Websites for Psoriasis
Download a Free Report Sample
Scope
This report assesses key digital marketing metrics of pharma assets in PsO, including branded websites for patients and HCPs, Unbranded websites, and social media accounts.
Metrics include website traffic volume, engagement, and source, DDA, paid SEO, and social media post interaction.
Countries include the US, 4EU (Italy, France, Germany, and Spain), the UK, and Canada (EUCAN).
Reasons to Buy
- Understand the digital marketing competitive landscape in PsO, to lead patient and HCP branded assets across different regions.
- See what tactics pharma companies are using to drive traffic to their PsO branded assets for patients and HCPs, such as DDA and paid SEO.
- Understand what sources of website traffic are generating the most visits to these assets, such as paid SEO, social media, or organic searches.
- Compare top branded and unbranded assets for patients by how they address and support different patient needs.
Novartis
Amgen
and Janssen
Table of Contents
Frequently asked questions
-
Which are the key US-branded patient websites for psoriasis?
The key US-branded patient websites for psoriasis are AbbVie’s Skyrizi.com, Amgen’s Otezla.com, AbbVie’s Humira.com, Novartis’s Cosentyx.com, and Janssen’s Tremfya.com, among others.
-
Which are the key US-branded HCP websites for psoriasis?
The key US-branded HCP websites for psoriasis are Amgen’s Otezla.com, AbbVie’s Skyrizihcp.com, Amgen’s Enbrelpro.com, Novartis’s Cosentyxhcp.com, and AbbVie’s Humira.com, among others.
-
Which website achieved the highest traffic across psoriasis HCP sites in the US from January 2023 to December 2023?
Amgen’s Otezlapro.com achieved the highest traffic across psoriasis HCP sites in the US from January 2023 to December 2023.
-
Which are the key EUCAN-branded websites for psoriasis?
The key EUCAN-branded websites for psoriasis are Abbvie-care.de, Ucbcares.de, and Abbviecare.fr.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Related reports
View more Psoriasis reports



